BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16121053)

  • 1. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
    Belisle A; Gautier MS; Ghozali F; Plantier F; Wechsler J
    Am J Dermatopathol; 2005 Aug; 27(4):319-21. PubMed ID: 16121053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collision tumor composed of Merkel cell carcinoma and lentigo maligna melanoma.
    Forman SB; Vidmar DA; Ferringer TC
    J Cutan Pathol; 2008 Feb; 35(2):203-6. PubMed ID: 18190446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent lentigo maligna melanoma commingling the tumour nests of a basal cell carcinoma.
    Hassan Z; Ahmad F; Brackley P
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):e227-8. PubMed ID: 23623186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasitism of basal cell carcinoma by lentigo maligna melanoma.
    Wang H; Benda PM; Piepkorn MW
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S92-4. PubMed ID: 12734489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
    Ren M; Kong YY; Shen XX; Cai X; Kong JC
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
    [No Abstract]   [Full Text] [Related]  

  • 9. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.
    King R; Page RN; Googe PB; Mihm MC
    Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentigo maligna involving the tumour nests and stroma of a nodular basal cell carcinoma.
    Taibjee SM; Gee BC; Sanders DS; Smith A; Carr RA
    Br J Dermatol; 2007 Jul; 157(1):184-8. PubMed ID: 17578442
    [No Abstract]   [Full Text] [Related]  

  • 11. Follicular malignant melanoma: a variant of melanoma to be distinguished from lentigo maligna melanoma.
    Hantschke M; Mentzel T; Kutzner H
    Am J Dermatopathol; 2004 Oct; 26(5):359-63. PubMed ID: 15365365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
    Ahlgrimm-Siess V; Massone C; Scope A; Fink-Puches R; Richtig E; Wolf IH; Koller S; Gerger A; Smolle J; Hofmann-Wellenhof R
    Br J Dermatol; 2009 Dec; 161(6):1307-16. PubMed ID: 19566662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma colonized by lentigo maligna melanoma, with perineural invasion by both neoplasms.
    Pérez-Pérez M; Umbría-Jiménez S; Mora-Cabeza M; Fernández-Orland A; Ríos-Martín JJ
    J Cutan Pathol; 2020 Dec; 47(12):1232-1236. PubMed ID: 32989833
    [No Abstract]   [Full Text] [Related]  

  • 14. Superficial dermal melanocytosis of the elderly: An exceptional occurrence?
    Saggini A; Dill D; Kleimann P; Kutzner H
    J Cutan Pathol; 2020 Sep; 47(9):865-869. PubMed ID: 32388873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
    Magro CM; Yang SE; Zippin JH; Zembowicz A
    Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative immunohistochemical evaluation of lentigo maligna and pigmented solar keratosis.
    Lane H; O'Loughlin S; Powell F; Magee H; Dervan PA
    Am J Clin Pathol; 1993 Dec; 100(6):681-5. PubMed ID: 8249917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma in situ colonizing basal cell carcinoma. A simulator of invasive melanoma.
    Burkhalter A; White WL
    Am J Dermatopathol; 1997 Jun; 19(3):303-7. PubMed ID: 9185921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous conjunctival melanoma and lentigo maligna melanoma.
    Volpini BMF; Maia M; Agi J; Vital J; Lellis RF
    An Bras Dermatol; 2017; 92(4):565-567. PubMed ID: 28954115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections.
    Tannous ZS; Mihm MC; Flotte TJ; González S
    J Am Acad Dermatol; 2002 Feb; 46(2):260-3. PubMed ID: 11807439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.